Deflazacort

(Emflaza®)

Deflazacort

Drug updated on 11/13/2023

Dosage FormTablet (oral: 6 mg, 18 mg, 30 mg, 36 mg); Suspension (oral: 22.75 mg/ml)
Drug ClassCorticosteroids
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • To treat Duchenne muscular dystrophy in patients ≥ 5 years of age.

Product Monograph / Prescribing Information

Document TitleYearSource
Emflaza (deflazacort) Prescribing Information.2021PTC Therapeutics, Inc., South Plainfield, NJ

Systematic Reviews / Meta-Analyses